結果ページ2 セクター：医療 産業：製薬会社（一般） 株式市場―見積もりと価格
価格、時価総額、PE、EPSを含む全株式と自己資本のリスト
すべての国
全取引所
- {{item.name}}
- 全取引所
- ASX (1)
- BSE (10)
- Budapest (1)
- Buenos Aires (12)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (44)
- Helsinki (2)
- HKSE (1)
- IOB (16)
- Istanbul (1)
- KSE (3)
- Mexico (14)
- Milan (5)
- Munich (1)
- NSE (8)
- NYSE (6)
- OTC Markets OTCPK (28)
- OTC Markets OTCQX (4)
- Paris (2)
- Santiago (4)
- São Paulo (14)
- SES (1)
- Shanghai (4)
- Shenzhen (4)
- Stockholm (3)
- Swiss (5)
- Taipei Exchange (1)
- Tech Market Large (4)
- Tech Market Middle (1)
- Tech Market Small (1)
- Tokyo (7)
- Vienna (13)
- XETRA (12)
製薬会社（一般） (243)
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 |
|---|
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Novartis AG NVSN.MX | MX$2,338.00 138.44 USD |
0
|
MX$4.49T 265.63B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$4.49T 265.63B USD | 17.39 | MX$134.44 7.96 USD | |
| Roche Holding AG RHO6.F | €38.61 42.21 USD |
+2.77
|
€237.00B 259.07B USD | €20.00 21.86 USD | €38.61 42.21 USD | €38.61 42.21 USD | €237.00B 259.07B USD | 24.59 | €1.57 1.72 USD | |
| AstraZeneca PLC ZEG.F | €152.75 166.98 USD |
-0.81
|
€236.80B 258.86B USD | €82.00 89.64 USD | €152.25 166.43 USD | €152.80 167.03 USD | €236.80B 258.86B USD | 29.31 | €5.21 5.7 USD | |
| AstraZeneca PLC ZEGA.F | €76.00 83.08 USD |
-0.65
|
€235.64B 257.59B USD | €70.00 76.52 USD | €76.00 83.08 USD | €76.00 83.08 USD | €235.64B 257.59B USD | 29.23 | €2.60 2.84 USD | |
| Gilead Sciences, Inc. GILD.BA | ARS 45,000.00 53.19 USD |
+3.26
|
ARS 213.20T 252.01B USD | ARS 281.00 0.33 USD | ARS 43,560.00 51.49 USD | ARS 45,080.00 53.29 USD | ARS 213.20T 252.01B USD | 4.94 | ARS 9.10K 10.76 USD | |
| Merck & Co., Inc. MRK.MX | MX$1,660.00 98.29 USD |
+3.95
|
MX$4.13T 244.5B USD | MX$1.01K 60.04 USD | MX$1,645.00 97.4 USD | MX$1,660.00 98.29 USD | MX$4.13T 244.5B USD | 11.90 | MX$139.42 8.26 USD | |
| Merck & Co., Inc. MRK.SN | $89.12 — |
+12.61
|
$242.47B — | $0.00 — | $89.12 — | $89.12 — | $242.47B — | 11.78 | $7.56 — | |
| Merck & Co., Inc. MRCK34.SA | R$59.70 12.1 USD |
+4.08
|
R$1.20T 242.27B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$1.20T 242.27B USD | 11.84 | R$5.04 1.02 USD | |
| Pfizer Inc. PFE.BA | ARS 9,370.00 11.08 USD |
+4.34
|
ARS 203.81T 240.91B USD | ARS 42.12K 49.79 USD | ARS 8,900.00 10.52 USD | ARS 9,380.00 11.09 USD | ARS 203.81T 240.91B USD | 1.93 | ARS 4.85K 5.73 USD | |
| Novartis AG NOTA.F | €110.50 120.79 USD |
-0.9
|
€212.03B 231.77B USD | €2.00 2.19 USD | €110.50 120.79 USD | €110.50 120.79 USD | €212.03B 231.77B USD | 17.45 | €6.33 6.92 USD | |
| Merck & Co., Inc. 6MK.DE | €78.80 86.14 USD |
+1.68
|
€197.10B 215.46B USD | €1.25K 1.37K USD | €78.70 86.03 USD | €78.90 86.25 USD | €197.10B 215.46B USD | 12.03 | €6.55 7.16 USD | |
| Merck & Co., Inc. 6MK.F | €78.70 86.03 USD |
+0.51
|
€196.32B 214.61B USD | €351.00 383.69 USD | €78.40 85.7 USD | €78.80 86.14 USD | €196.32B 214.61B USD | 12.01 | €6.55 7.16 USD | |
| Merck & Co., Inc. MRK.VI | €78.90 86.25 USD |
+1.94
|
€195.83B 214.07B USD | €125.00 136.64 USD | €78.70 86.03 USD | €78.90 86.25 USD | €195.83B 214.07B USD | 12.04 | €6.55 7.16 USD | |
| Amgen Inc. AMGN34.SA | R$63.13 12.8 USD |
+3.34
|
R$960.66B 194.71B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$960.66B 194.71B USD | 25.66 | R$2.46 0.5 USD | |
| Amgen Inc. AMGN.MX | MX$5,990.00 354.68 USD |
0
|
MX$3.23T 190.99B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$3.23T 190.99B USD | 25.12 | MX$238.40 14.12 USD | |
| Amgen Inc. AMGN.VI | €292.65 319.91 USD |
+2.85
|
€157.59B 172.26B USD | €0.00 0 USD | €292.65 319.91 USD | €292.65 319.91 USD | €157.59B 172.26B USD | 26.10 | €11.21 12.25 USD | |
| Amgen Inc. AMG.DE | €292.00 319.2 USD |
+2.73
|
€157.24B 171.88B USD | €381.00 416.48 USD | €291.65 318.81 USD | €292.30 319.52 USD | €157.24B 171.88B USD | 26.04 | €11.21 12.25 USD | |
| Amgen Inc. AMG.F | €291.35 318.48 USD |
+2.21
|
€156.89B 171.5B USD | €62.00 67.77 USD | €291.05 318.16 USD | €294.00 321.38 USD | €156.89B 171.5B USD | 26.01 | €11.20 12.24 USD | |
| GSK plc GSK.BA | ARS 17,800.00 21.04 USD |
+1.66
|
ARS 143.05T 169.09B USD | ARS 589.00 0.7 USD | ARS 17,620.00 20.83 USD | ARS 17,890.00 21.15 USD | ARS 143.05T 169.09B USD | 14.30 | ARS 1.24K 1.47 USD | |
| Bristol-Myers Squibb Company BMY.BA | ARS 23,790.00 28.12 USD |
+2.19
|
ARS 138.48T 163.69B USD | ARS 1.04K 1.23 USD | ARS 23,290.00 27.53 USD | ARS 23,870.00 28.22 USD | ARS 138.48T 163.69B USD | 5.68 | ARS 4.18K 4.94 USD | |
| Gilead Sciences, Inc. GILD.MX | MX$2,215.00 131.16 USD |
-3.19
|
MX$2.75T 162.72B USD | MX$10.00 0.59 USD | MX$2,215.00 131.16 USD | MX$2,215.00 131.16 USD | MX$2.75T 162.72B USD | 18.58 | MX$119.20 7.06 USD | |
| Pfizer Inc. PFE.SN | $27.75 — |
+6.49
|
$157.78B — | $0.00 — | $27.75 — | $27.75 — | $157.78B — | 16.13 | $1.72 — | |
| Amgen Inc. 0R0T.IL | $287.63 — |
+0.57
|
$157.63B — | $1.00 — | $0.00 — | $0.00 — | $157.63B — | 19.38 | $14.84 — | |
| Gilead Sciences, Inc. GILD34.SA | R$313.20 63.48 USD |
-1.56
|
R$777.16B 157.52B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$777.16B 157.52B USD | 18.19 | R$17.21 3.49 USD | |
| Pfizer Inc. PFE.MX | MX$466.47 27.62 USD |
+3.75
|
MX$2.65T 157.16B USD | MX$38.06K 2.25K USD | MX$449.00 26.59 USD | MX$466.47 27.62 USD | MX$2.65T 157.16B USD | 14.69 | MX$31.74 1.88 USD | |
| Pfizer Inc. PFIZ34.SA | R$33.43 6.78 USD |
+3.34
|
R$764.37B 154.93B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$764.37B 154.93B USD | 14.59 | R$2.29 0.46 USD | |
| Gilead Sciences, Inc. GILD.SN | $110.29 — |
-0.13
|
$146.40B — | $0.00 — | $110.29 — | $110.29 — | $146.40B — | 17.07 | $6.46 — | |
| Gilead Sciences, Inc. GIS.DE | €105.36 115.17 USD |
+1.27
|
€133.20B 145.61B USD | €258.00 282.03 USD | €105.36 115.17 USD | €105.64 115.48 USD | €133.20B 145.61B USD | 18.84 | €5.59 6.11 USD | |
| Gilead Sciences, Inc. GIS.F | €105.72 115.57 USD |
+3.55
|
€133.08B 145.48B USD | €285.00 311.54 USD | €105.72 115.57 USD | €105.72 115.57 USD | €133.08B 145.48B USD | 18.87 | €5.60 6.12 USD | |
| Gilead Sciences, Inc. GILD.VI | €105.84 115.7 USD |
+1.61
|
€131.31B 143.54B USD | €0.00 0 USD | €105.84 115.7 USD | €105.84 115.7 USD | €131.31B 143.54B USD | 18.93 | €5.59 6.11 USD | |
| Pfizer Inc. PFE.VI | €22.00 24.04 USD |
+2.73
|
€125.06B 136.7B USD | €0.00 0 USD | €22.00 24.04 USD | €22.00 24.04 USD | €125.06B 136.7B USD | 14.76 | €1.49 1.63 USD | |
| Pfizer Inc. PFEB.F | €6.90 7.54 USD |
+5.34
|
€116.07B 126.88B USD | €50.00 54.66 USD | €6.90 7.54 USD | €6.90 7.54 USD | €116.07B 126.88B USD | 13.52 | €0.51 0.56 USD | |
| Sanofi SNW.F | €89.65 98 USD |
+0.4
|
€110.62B 120.92B USD | €330.00 360.73 USD | €89.09 97.39 USD | €89.65 98 USD | €110.62B 120.92B USD | 17.10 | €5.24 5.73 USD | |
| Sanofi SANO.VI | €89.50 97.84 USD |
+1.3
|
€109.01B 119.16B USD | €129.00 141.01 USD | €89.50 97.84 USD | €89.64 97.99 USD | €109.01B 119.16B USD | 17.08 | €5.24 5.73 USD | |
| Sanofi SNW2.F | €44.40 48.54 USD |
+0.91
|
€108.16B 118.23B USD | €20.00 21.86 USD | €44.40 48.54 USD | €44.40 48.54 USD | €108.16B 118.23B USD | 16.94 | €2.62 2.86 USD | |
| Bristol-Myers Squibb Company BMY.MX | MX$887.00 52.52 USD |
+3.12
|
MX$1.83T 108.38B USD | MX$554.00 32.8 USD | MX$883.30 52.3 USD | MX$887.00 52.52 USD | MX$1.83T 108.38B USD | 16.18 | MX$54.79 3.24 USD | |
| GSK plc GSKN.MX | MX$866.15 51.29 USD |
+0.05
|
MX$1.78T 105.18B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$1.78T 105.18B USD | 13.44 | MX$64.41 3.81 USD | |
| Bristol-Myers Squibb Company BMYB34.SA | R$250.25 50.72 USD |
0
|
R$513.17B 104.01B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$513.17B 104.01B USD | 15.79 | R$15.84 3.21 USD | |
| GSK plc G1SK34.SA | R$50.69 10.27 USD |
+2.72
|
R$511.09B 103.59B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$511.09B 103.59B USD | 13.66 | R$3.71 0.75 USD | |
| Bristol-Myers Squibb Company BMYS.VI | €42.28 46.22 USD |
+3.22
|
€86.07B 94.09B USD | €0.00 0 USD | €42.28 46.22 USD | €42.28 46.22 USD | €86.07B 94.09B USD | 16.45 | €2.57 2.81 USD | |
| Bristol-Myers Squibb Company BRM.F | €42.15 46.07 USD |
+0.35
|
€85.80B 93.79B USD | €275.00 300.61 USD | €42.15 46.07 USD | €42.15 46.07 USD | €85.80B 93.79B USD | 16.39 | €2.57 2.81 USD | |
| Bristol-Myers Squibb Company BRM.DE | €42.08 45.99 USD |
+1.29
|
€85.65B 93.63B USD | €330.00 360.73 USD | €42.33 46.27 USD | €42.33 46.27 USD | €85.65B 93.63B USD | 16.37 | €2.57 2.81 USD | |
| GSK GLAXF | $22.75 — |
-1.64
|
$93.58B — | $1.13K — | $23.25 — | $23.50 — | $93.58B — | 13.00 | $1.75 — | |
| Chugai Pharmaceutical CHGCF | $46.37 — |
-4.11
|
$80.29B — | $100.00 — | $45.50 — | $45.50 — | $80.29B — | 29.72 | $1.56 — | |
| Chugai Pharmaceutical Co., Ltd. CUP.F | €43.45 47.5 USD |
+4.05
|
€71.51B 78.17B USD | €50.00 54.66 USD | €43.41 47.45 USD | €43.45 47.5 USD | €71.51B 78.17B USD | 32.18 | €1.35 1.48 USD | |
| Daiichi Sankyo Company, Limited D4S.F | €19.07 20.84 USD |
-1.09
|
€39.77B 43.47B USD | €290.00 317.01 USD | €19.07 20.84 USD | €19.07 20.84 USD | €39.77B 43.47B USD | 22.69 | €0.84 0.92 USD | |
| Biogen Inc. BIIB.BA | ARS 17,910.00 21.17 USD |
+0.79
|
ARS 32.54T 38.47B USD | ARS 523.00 0.62 USD | ARS 17,680.00 20.9 USD | ARS 18,040.00 21.32 USD | ARS 32.54T 38.47B USD | 1.15 | ARS 15.45K 18.26 USD | |
| Bayer Aktiengesellschaft BAYZF | $31.72 — |
+3.69
|
$31.16B — | $2.46K — | $30.97 — | $31.76 — | $31.16B — | 0 | -$4.02 — | |
| Bayer Aktiengesellschaft BAYN.VI | €28.41 31.05 USD |
+3.55
|
€27.91B 30.5B USD | €3.27K 3.57K USD | €27.56 30.12 USD | €28.44 31.08 USD | €27.91B 30.5B USD | 0 | -€3.48 -3.8 USD | |
| Bayer Aktiengesellschaft BAYA.F | €6.55 7.16 USD |
+1.55
|
€26.89B 29.39B USD | €1.80K 1.97K USD | €6.55 7.16 USD | €6.55 7.16 USD | €26.89B 29.39B USD | 0 | -€0.87 -0.9 USD | |
| Bayer Aktiengesellschaft BAYER.BD | HUF 10,100.00 27.93 USD |
0
|
HUF 10.30T 28.49B USD | HUF 25.00 0.07 USD | HUF 10,100.00 27.93 USD | HUF 10,100.00 27.93 USD | HUF 10.30T 28.49B USD | 0 | -HUF 1,342.00 -3.7 USD | |
| Otsuka Holdings Co., Ltd. OS1.F | €46.60 50.94 USD |
+1.75
|
€25.38B 27.74B USD | €20.00 21.86 USD | €46.60 50.94 USD | €46.60 50.94 USD | €25.38B 27.74B USD | 10.86 | €4.29 4.69 USD | |
| Biogen Inc. BIIB.MX | MX$2,790.00 165.2 USD |
0
|
MX$422.93B 25.04B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$422.93B 25.04B USD | 13.79 | MX$202.27 11.98 USD | |
| Biogen Inc. BIIB34.SA | R$139.01 28.18 USD |
-0.31
|
R$122.85B 24.9B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$122.85B 24.9B USD | 14.30 | R$9.72 1.97 USD | |
| Biogen Inc. IDP.DE | €138.10 150.96 USD |
+2.52
|
€20.26B 22.15B USD | €102.00 111.5 USD | €136.70 149.43 USD | €138.35 151.24 USD | €20.26B 22.15B USD | 14.52 | €9.51 10.4 USD | |
| Biogen Inc. BIIB.VI | €137.90 150.74 USD |
+2.3
|
€20.23B 22.11B USD | €0.00 0 USD | €137.90 150.74 USD | €137.90 150.74 USD | €20.23B 22.11B USD | 14.51 | €9.50 10.38 USD | |
| Biogen Inc. IDP.F | €137.35 150.14 USD |
+2.31
|
€20.15B 22.03B USD | €21.00 22.96 USD | €137.35 150.14 USD | €137.35 150.14 USD | €20.15B 22.03B USD | 14.45 | €9.50 10.38 USD | |
| Astellas Pharma ALPMF | $11.31 — |
+2.08
|
$20.80B — | $100.00 — | $10.80 — | $10.80 — | $20.80B — | 25.13 | $0.45 — | |
| Astellas Pharma Inc. YPH.F | €10.15 11.09 USD |
+5.35
|
€18.17B 19.86B USD | €50.00 54.66 USD | €10.15 11.09 USD | €10.15 11.09 USD | €18.17B 19.86B USD | 26.01 | €0.39 0.43 USD | |
| Astellas Pharma Inc. YPHA.F | €10.00 10.93 USD |
+3.09
|
€17.91B 19.58B USD | €379.00 414.3 USD | €10.00 10.93 USD | €10.00 10.93 USD | €17.91B 19.58B USD | 25.64 | €0.39 0.43 USD | |
| Cipla Limited CIPLA.BO | ₹1,518.20 18.37 USD |
+0.22
|
₹1.23T 14.84B USD | ₹105.12K 1.27K USD | ₹1,507.60 18.24 USD | ₹1,528.00 18.49 USD | ₹1.23T 14.84B USD | 22.57 | ₹67.26 0.81 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. RER1.F | €53.50 58.48 USD |
+4.09
|
€11.21B 12.25B USD | €55.00 60.12 USD | €51.80 56.62 USD | €53.70 58.7 USD | €11.21B 12.25B USD | 27.57 | €1.94 2.12 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.VI | €51.60 56.41 USD |
0
|
€10.55B 11.53B USD | €0.00 0 USD | €50.55 55.26 USD | €51.60 56.41 USD | €10.55B 11.53B USD | 26.46 | €1.95 2.13 USD | |
| Orion Oyj ORINF | $81.30 — |
0
|
$11.16B — | $100.00 — | $81.30 — | $81.30 — | $11.16B — | 26.05 | $3.12 — | |
| CSPC Pharmaceutical Group Limited CVG.F | €0.83 0.91 USD |
+0.92
|
€9.78B 10.69B USD | €2.00K 2.19K USD | €0.83 0.91 USD | €0.83 0.91 USD | €9.78B 10.69B USD | 20.76 | €0.04 0.04 USD | |
| Orion Oyj OFK0.F | €30.00 32.79 USD |
+4.17
|
€8.88B 9.71B USD | €500.00 546.57 USD | €30.00 32.79 USD | €30.00 32.79 USD | €8.88B 9.71B USD | 26.78 | €1.12 1.22 USD | |
| Orion Oyj ORINY | $34.10 — |
+10.39
|
$9.69B — | $2.00 — | $34.18 — | $34.18 — | $9.69B — | 26.43 | $1.29 — | |
| Orion Oyj OFK.F | €60.15 65.75 USD |
+0.84
|
€8.83B 9.65B USD | €24.00 26.24 USD | €60.15 65.75 USD | €60.15 65.75 USD | €8.83B 9.65B USD | 26.97 | €2.23 2.44 USD | |
| Grifols, S.A. GIFOF | $8.82 — |
0
|
$8.60B — | $4.41K — | $8.18 — | $8.25 — | $8.60B — | 16.95 | $0.52 — | |
| Grifols GIFLF | $13.90 — |
0
|
$8.25B — | $500.00 — | $14.00 — | $14.00 — | $8.25B — | 27.25 | $0.51 — | |
| Kyowa Kirin Co., Ltd. KY4.F | €13.60 14.87 USD |
+1.49
|
€7.12B 7.78B USD | €15.00 16.4 USD | €13.50 14.76 USD | €13.60 14.87 USD | €7.12B 7.78B USD | 33.17 | €0.41 0.45 USD | |
| Grifols, S.A. G0F.F | €5.05 5.52 USD |
-9.01
|
€6.94B 7.58B USD | €68.00 74.33 USD | €5.05 5.52 USD | €5.05 5.52 USD | €6.94B 7.58B USD | 18.70 | €0.27 0.3 USD | |
| Abbott India Limited ABBOTINDIA.BO | ₹29,393.90 355.62 USD |
-0.51
|
₹624.60B 7.56B USD | ₹421.00 5.09 USD | ₹29,226.85 353.6 USD | ₹29,650.00 358.72 USD | ₹624.60B 7.56B USD | 41.45 | ₹709.05 8.58 USD | |
| Grifols, S.A. GRF.VI | €10.68 11.67 USD |
+1.33
|
€6.90B 7.55B USD | €0.00 0 USD | €10.68 11.67 USD | €10.68 11.67 USD | €6.90B 7.55B USD | 19.41 | €0.55 0.6 USD | |
| Grifols, S.A. OZTA.F | €10.58 11.57 USD |
-2.26
|
€6.89B 7.53B USD | €175.00 191.3 USD | €10.58 11.57 USD | €10.58 11.57 USD | €6.89B 7.53B USD | 19.23 | €0.55 0.6 USD | |
| Grifols, S.A. GIKLY | $6.01 — |
0
|
$7.36B — | $50.00 — | $6.70 — | $6.70 — | $7.36B — | 18.78 | $0.32 — | |
| Grifols, S.A. G0FB.F | €7.40 8.09 USD |
+2.78
|
€6.68B 7.3B USD | €300.00 327.94 USD | €7.40 8.09 USD | €7.40 8.09 USD | €6.68B 7.3B USD | 13.45 | €0.55 0.6 USD | |
| Kyowa Kirin KYKOF | $13.58 — |
0
|
$7.11B — | $100.00 — | $13.58 — | $13.58 — | $7.11B — | 28.29 | $0.48 — | |
| Ono Pharmaceutical OPHLF | $11.08 — |
-9.18
|
$5.95B — | $104.00 — | $12.22 — | $12.22 — | $5.95B — | 15.17 | $0.73 — | |
| Ono Pharmaceutical Co., Ltd. ON4.F | €10.90 11.92 USD |
+3.81
|
€5.12B 5.6B USD | €75.00 81.99 USD | €10.90 11.92 USD | €10.90 11.92 USD | €5.12B 5.6B USD | 17.30 | €0.63 0.69 USD | |
| Ono Pharmaceutical Co., Ltd. ON4.MU | €10.90 11.92 USD |
+3.81
|
€5.12B 5.6B USD | €0.00 0 USD | €10.90 11.92 USD | €10.90 11.92 USD | €5.12B 5.6B USD | 17.30 | €0.63 0.69 USD | |
| GlaxoSmithKline Pharmaceuticals Limited GLAXO.BO | ₹2,504.50 30.3 USD |
+1.12
|
₹449.54B 5.44B USD | ₹3.06K 37.03 USD | ₹2,477.50 29.97 USD | ₹2,536.00 30.68 USD | ₹449.54B 5.44B USD | 44.35 | ₹56.47 0.68 USD | |
| GlaxoSmithKline Pharmaceuticals Limited GLAXO.NS | ₹2,503.50 30.29 USD |
+1.1
|
₹449.45B 5.44B USD | ₹93.95K 1.14K USD | ₹2,473.10 29.92 USD | ₹2,536.60 30.69 USD | ₹449.45B 5.44B USD | 44.34 | ₹56.46 0.68 USD | |
| Gland Pharma Limited GLAND.BO | ₹1,853.50 22.42 USD |
+0.23
|
₹318.53B 3.85B USD | ₹1.85K 22.43 USD | ₹1,777.60 21.51 USD | ₹1,886.90 22.83 USD | ₹318.53B 3.85B USD | 38.69 | ₹47.90 0.58 USD | |
| Gland Pharma Limited GLAND.NS | ₹1,850.60 22.39 USD |
-0.03
|
₹317.70B 3.84B USD | ₹61.28K 741.41 USD | ₹1,844.00 22.31 USD | ₹1,886.90 22.83 USD | ₹317.70B 3.84B USD | 38.59 | ₹47.95 0.58 USD | |
| PT Kalbe Farma Tbk PTKFF | $0.08 — |
0
|
$3.63B — | $4.00K — | $0.06 — | $0.06 — | $3.63B — | 0 | $0.00 — | |
| Virbac SA VIRP.PA | €357.00 390.25 USD |
+0.71
|
€3.07B 3.35B USD | €168.00 183.65 USD | €355.50 388.61 USD | €359.00 392.44 USD | €3.07B 3.35B USD | 22.46 | €15.89 17.37 USD | |
| Virbac SA 0NM7.IL | €357.00 390.25 USD |
+0.63
|
€3.04B 3.33B USD | €1.00 1.09 USD | €357.00 390.25 USD | €358.50 391.89 USD | €3.04B 3.33B USD | 25.51 | €13.99 15.29 USD | |
| Virbac SA V16.F | €353.00 385.88 USD |
+1.59
|
€3.03B 3.31B USD | €117.00 127.9 USD | €347.50 379.86 USD | €353.00 385.88 USD | €3.03B 3.31B USD | 22.24 | €15.87 17.35 USD | |
| Santen Pharmaceutical SNPHF | $10.11 — |
0
|
$3.28B — | $200.00 — | $12.46 — | $12.64 — | $3.28B — | 16.84 | $0.60 — | |
| Santen Pharmaceutical Co., Ltd. SZD.F | €8.30 9.07 USD |
-1.78
|
€2.74B 2.99B USD | €23.00 25.14 USD | €8.30 9.07 USD | €8.30 9.07 USD | €2.74B 2.99B USD | 15.96 | €0.52 0.57 USD | |
| Pfizer Limited PFIZER.BO | ₹5,015.25 60.68 USD |
+0.38
|
₹239.21B 2.89B USD | ₹353.00 4.27 USD | ₹4,990.95 60.38 USD | ₹5,101.00 61.71 USD | ₹239.21B 2.89B USD | 28.35 | ₹176.87 2.14 USD | |
| Pfizer Limited PFIZER.NS | ₹4,998.50 60.47 USD |
+0.03
|
₹238.37B 2.88B USD | ₹15.52K 187.78 USD | ₹4,988.50 60.35 USD | ₹5,115.50 61.89 USD | ₹238.37B 2.88B USD | 28.25 | ₹176.89 2.14 USD | |
| Haw Par Corporation Limited HAWPY | $50.80 — |
0
|
$2.81B — | $10.00 — | $46.98 — | $46.98 — | $2.81B — | 14.63 | $3.47 — | |
| Haw Par HAWPF | $10.66 — |
0
|
$2.58B — | $100.00 — | $10.62 — | $10.62 — | $2.58B — | 12.25 | $0.87 — | |
| Organon & Co. OGN.MX | MX$138.50 8.2 USD |
+0.36
|
MX$37.11B 2.2B USD | MX$224.00 13.26 USD | MX$138.50 8.2 USD | MX$138.50 8.2 USD | MX$37.11B 2.2B USD | 3.94 | MX$35.12 2.08 USD | |
| Organon & Co. 7XP.F | €6.48 7.08 USD |
-1.52
|
€1.68B 1.84B USD | €758.00 828.6 USD | €6.48 7.08 USD | €6.48 7.09 USD | €1.68B 1.84B USD | 3.92 | €1.65 1.8 USD | |
| Luye Pharma Group Ltd. LUP.F | €0.35 0.38 USD |
+3.55
|
€1.44B 1.57B USD | €20.00 21.86 USD | €0.35 0.38 USD | €0.35 0.38 USD | €1.44B 1.57B USD | 35.00 | €0.01 0.01 USD | |
| Sanofi India Limited SANOFI.BO | ₹4,613.00 55.81 USD |
+0.57
|
₹110.71B 1.34B USD | ₹496.00 6 USD | ₹4,586.00 55.48 USD | ₹4,622.90 55.93 USD | ₹110.71B 1.34B USD | 29.84 | ₹154.58 1.87 USD | |
| Sanofi India Limited SANOFI.NS | ₹4,607.00 55.74 USD |
+0.51
|
₹110.64B 1.34B USD | ₹7.00K 84.74 USD | ₹4,584.00 55.46 USD | ₹4,625.90 55.97 USD | ₹110.64B 1.34B USD | 29.82 | ₹154.47 1.87 USD | |
|
お気に入り銘柄なし
お気に入りの株式はまだありません。ここで表示するにはお気に入りに追加してください |
||||||||||
- {{ link.label }} {{link}}